Ownership history in Core Alternative Capital · 16 quarters on record
This page tracks every 13F SEC filing in which Core Alternative Capital reported a position in RESMED INC (RMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 2 | — | 0% | 0.00% | $547 | $272.45 |
| 2025 Q2 | UNCHANGED | 2 | — | 0% | 0.00% | $516 | $256.26 |
| 2025 Q1 | UNCHANGED | 2 | — | 0% | 0.00% | $448 | $221.86 |
| 2024 Q4 | UNCHANGED | 2 | — | 0% | 0.00% | $457 | $226.15 |
| 2024 Q3 | UNCHANGED | 2 | — | 0% | 0.00% | $488 | $240.88 |
| 2024 Q2 | UNCHANGED | 2 | — | 0% | 0.00% | $383 | $188.43 |
| 2024 Q1 | REDUCED | 2 | -40 | -95.2% | 0.00% | $396 | $194.51 |
| 2023 Q4 | REDUCED | 42 | -2 | -4.5% | 0.00% | $7K | $168.53 |
| 2023 Q3 | UNCHANGED | 44 | — | 0% | 0.00% | $7K | $144.41 |
| 2023 Q2 | ADDED | 44 | +4 | +10.0% | 0.00% | $10K | $212.83 |
As of 2025 Q4 — sorted by position size